Many in the field argue that these cases may represent phenocopies of RB1 loss—through mechanisms such as CDK4/6 hyperactivation, p16INK4A loss, or functional inactivation via upstream deregulation—rather than truly RB1-proficient SCLC [38,94]. This evidence concerns the gene RB1 and small cell lung carcinoma.